Ashwani Verma
Stock Analyst at UBS
(0.86)
# 2081
Out of 5,329 analysts
74
Total ratings
42.86%
Success rate
-0.89%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
HRMY Harmony Biosciences ... | Maintains: Buy | 55 48 | 29.9 | 60.54% | 2 | Apr 28, 2025 | |
ACAD ACADIA Pharmaceutica... | Maintains: Buy | 25 22 | 14.59 | 50.79% | 4 | Apr 28, 2025 | |
ALKS Alkermes | Maintains: Neutral | 38 33 | 30.63 | 7.74% | 4 | Apr 28, 2025 | |
CHRS Coherus BioSciences | Maintains: Neutral | 2 2 | 1.03 | 1.94% | 5 | Apr 24, 2025 | |
NBIX Neurocrine Bioscienc... | Maintains: Buy | 154 137 | 106.71 | 28.39% | 7 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 145 179 | 117.19 | 52.74% | 6 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 30 27 | 15.63 | 72.74% | 8 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 30 34 | 38.9 | -12.6% | 2 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 22 14 | 8.62 | 62.41% | 2 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 415 475 | 293.57 | 61.8% | 4 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 106 114 | 65.69 | 73.54% | 2 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 55 54 | 22.56 | 139.36% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 83 79 | n/a | n/a | 5 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 107 105 | 112.47 | -6.64% | 2 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 28 | 32.49 | -13.82% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 76 81 | 34 | 138.24% | 2 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 61 92 | 43.03 | 113.8% | 4 | Jan 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 11 7 | 69.21 | -89.89% | 1 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 209 | n/a | n/a | 2 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 9 12 | 8.48 | 41.51% | 2 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 15 | 1.08 | 1288.89% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 137 71 | n/a | n/a | 3 | Aug 4, 2022 |